thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q38075446-032A7456-DC59-42F7-8EDE-299B2F234C1E
Q38075446-032A7456-DC59-42F7-8EDE-299B2F234C1E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38075446-032A7456-DC59-42F7-8EDE-299B2F234C1E
Tasquinimod: a novel angiogenesis inhibitor-development in prostate cancer.
P2860
Q38075446-032A7456-DC59-42F7-8EDE-299B2F234C1E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38075446-032A7456-DC59-42F7-8EDE-299B2F234C1E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4f291fa014eedf83071f0645919d66572d97480c
P2860
Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.